Send a Tweet
Most Popular Choices
Share on Facebook 1 Share on Twitter Printer Friendly Page More Sharing
Sci Tech    H3'ed 8/14/18

Opioid Abuse Mushrooming, with the nod of FDA

Quicklink Submitted By     (# of views)   No comments
Follow Me on Twitter     Message Josh Mitteldorf
Become a Fan
  (43 fans)

The FDA knew that doctors were wrongly prescribing opioid mouth sprays and lozenges (TIRFs) meant to provide immediate relief for breakthrough cancer pain in patients who have been taking opioids for long periods of time. TIRFs can kill patients who take them without having first developed tolerance. But they were prescribed to patients who had no tolerance, and for migraines or dental pain, a team at the Johns Hopkins said. The US is suffering an epidemic of opioid abuse. Opioids killed 42,000 people in 2016. The CDC reported last year, the number of prescriptions for the painkillers tripled from 1999 to 2015. “FDA had evidence as early as April 2016 that TIRFs were being prescribed for many patients who were not opioid tolerant,”, as many as 51 percent were not opioid tolerant.”   A recent CNN report titled, 'The more opioids doctors prescribe, the more money they make' 

Read the rest of the story HERE:

At www.nbcnews.com

 

- Advertisement -

News 1   Interesting 1   Valuable 1  
Rate It | View Ratings

Josh Mitteldorf Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in


Josh Mitteldorf, a senior editor at OpEdNews, blogs on aging at http://JoshMitteldorf.ScienceBlog.com. Read how to stay young at http://AgingAdvice.org.
Educated to be an astrophysicist, he has branched out from there to mathematical (more...)
 

Related Topic(s): ; , Add Tags
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)